BACK

To Her Credit

Joni Hanebutt / Shutterstock.com

To Her Credit

Menstrual products now classified as qualified medical expenses

As part of the CARES Act, you can now use an HSA or FSA to purchase menstrual products

To Her Credit offers targeted advice about personal finance based on unique challenges faced by women. It is authored by women with different financial backgrounds, dedicated to encouraging empowerment through financial literacy.

The content on this page is accurate as of the posting date; however, some of our partner offers may have expired. Please review our list of best credit cards, or use our CardMatch™ tool to find cards matched to your needs.

As part of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, menstrual care products are now considered a qualified medical expense eligible under the IRS Tax Code. As a result, these products can now be purchased with pretax income through a Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA).

This is not the first time Congress has attempted to include menstrual products as an eligible expense. In 2018, the Restoring Access to Medication and Modernizing Health Savings Accounts Act, which was passed in the House of Representatives, included a similar measure. The bill did not reach a vote in the senate.

The way menstrual products are taxed has long been debated. While these products are necessary for the health of people with periods, they are still considered a luxury in many places around the world. In fact, 30 states still charge a sales tax on menstrual products, classifying them as non-essential purchases – often known as the “tampon tax.”

See related: The pink tax: What it is and how you can battle it

Right now, it is unclear whether menstrual products will continue to be an eligible purchase with HSAs and FSAs when the CARES Act expires. But advocates are optimistic that their current status as a qualified medical expense will set an important precedent that could lead to lasting change.

“Now that the federal government has acknowledged that menstrual products are indeed a medical necessity for those of us who use them, new groundwork can be laid for more expansive policies on core issues of menstrual access and affordability …  [It is a] more far-reaching acknowledgement of the intersection of women’s health and the economy,” wrote Jennifer Weiss-Wolf and Julia Morrison in Ms. Magazine.

Founder of Period Equity – which advocates for accessible, affordable and safe menstrual products – Weiss-Wolf plans to use the CARES Act to strengthen Period Equity’s case for exempting sales tax on menstrual products in states where it still exists.

Whether this becomes a milestone for future change or not, it will at least provide a temporary relief for many facing financial hardship due to the coronavirus pandemic.

See related: The hidden cost of being a woman

Editorial Disclaimer

The editorial content on this page is based solely on the objective assessment of our writers and is not driven by advertising dollars. It has not been provided or commissioned by the credit card issuers. However, we may receive compensation when you click on links to products from our partners.

What’s up next?

In To Her Credit

Women in business: Making it as a female entrepreneur

Four out of every 10 U.S. businesses are owned by women, according to a 2019 Guidant Financial report – and those numbers are growing. Female entrepreneurs are a force to be reckoned with, and to hit their targets, they tap into their assets. Challenges abound in…

See more stories
Credit Card Rate Report Updated: August 5th, 2020
Business
13.91%
Airline
15.48%
Cash Back
16.09%
Reward
15.82%
Student
16.12%

Questions or comments?

Contact us

Editorial corrections policies

Learn more

Join the Discussion

We encourage an active and insightful conversation among our users. Please help us keep our community civil and respectful. For your safety, do not disclose confidential or personal information such as bank account numbers or social security numbers. Anything you post may be disclosed, published, transmitted or reused.

The editorial content on CreditCards.com is not sponsored by any bank or credit card issuer. The journalists in the editorial department are separate from the company’s business operations. The comments posted below are not provided, reviewed or approved by any company mentioned in our editorial content. Additionally, any companies mentioned in the content do not assume responsibility to ensure that all posts and/or questions are answered.